Company / Shares Outstanding
Oruka Therapeutics, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
16.8M
FY2024
5-year range
1.6M / 16.8M
FY2020-FY2024
Trend
+16.5%
vs FY2023
Sector context
#204 of 212
Health Care
What the data says
Among 212 Health Care companies, Oruka Therapeutics, Inc. is in the top 4% for shares outstanding. Increased from 14410143.00 to 16789362.00 over the past 2 years.
Based on SEC 10-K filings.
16789362.00 in FY2024 with a 5-year CAGR of +85.1%.
Increased from 14410143.00 to 16789362.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +20.7%
- 5-Year CAGR
- +85.1%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 212This company 16.8M Sector average 306.0M
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding increased 16.5% year-over-year.
- Ranks #204 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 16.8M | +16.5% |
| FY2023 | 14.4M | +0.0% |
| FY2022 | 14.4M | +50.9% |
| FY2021 | 9.5M | +499.0% |
| FY2020 | 1.6M | +106.1% |
| FY2019 | 773.6K | -93.4% |
| FY2018 | 11.8M | +29.6% |
| FY2017 | 9.1M | +0.3% |
| FY2016 | 9.1M | +199.6% |
| FY2015 | 3.0M | -80.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026